How should fibrinolysis (systemic or catheter‑directed) be performed in a patient with cerebral venous sinus thrombosis who is neurologically deteriorating despite therapeutic anticoagulation, has a large clot burden or severe intracranial hypertension, and no contraindications to thrombolysis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board

Educational purpose only • Exercise caution as content is pending human review

Article Review Status

Submitted

Under Review

Approved

Last updated: February 25, 2026 • View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Related Questions

What is the appropriate acute and subsequent management for a transgender woman on feminizing hormone therapy who presents with cerebral venous sinus thrombosis (CVST) complicated by intracranial hemorrhage (ICH)?

What is the cause of bleeding in cerebral venous sinus thrombosis (CVST) patients who have not received low‑molecular‑weight heparin (LMWH)?

Is cerebral venous sinus thrombosis (CVST) more prevalent in certain racial or ethnic groups?

What is the most appropriate initial management for a patient with left transverse sinus thrombosis (cerebral venous sinus thrombosis) who presents with a seizure?

What is the initial management for a patient with cerebral venous thrombosis, assuming no contraindications to anticoagulation?

In a clinically stable patient with a tracheostomy‑associated respiratory infection who is afebrile and improving, how many days should meropenem be continued?

Is it safe to proceed with kidney donation from a donor with active genital HSV‑1 infection, and what antiviral treatment and prophylaxis are required for donor and recipient?

What is the proper technique, indications, duration, additives, and contraindications for a sitz bath?

Should a young adult with intermittent brief palpitations, dizziness, a sensation of a slowed heart, and a normal resting ECG undergo a cardiology evaluation before starting psychostimulant therapy?

What is the step‑by‑step protocol for intrapleural fibrinolytic therapy in a hemodynamically stable patient with a loculated parapneumonic effusion or empyema, who already has a chest tube in place and no contraindications such as recent intracranial hemorrhage, coagulopathy (INR > 1.5 or platelets < 50,000/µL), or hypersensitivity to the fibrinolytic agent?

When should phenazopyridine be used instead of flavoxate for urinary symptoms, and what are the dosing regimens and contraindications for each?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.